ArticleFood science & nutrition2025
Differences in the Effects of Saturated and Trans Fatty Acids on Metabolism and Anxiety-Like Behavior in Mice.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differences in the Effects of Saturated and Trans Fatty Acids on Metabolism and Anxiety-Like Behavior in Mice.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-fat diets (HFDs) are linked to obesity, metabolic disorders, and increased anxiety and depression risks. However, the differential effects of saturated fatty acids (SFA) and trans-fatty acids (TFA) on neuronal-type nitric oxide synthase (nNOS) regulation of anxiety, metabolism, and mood remain unclear. This study aimed to compare the long-term impacts of SFA and TFA on obesity, metabolism, and anxiety-like behaviors, and to evaluate the role of nNOS in these processes. Mice were fed SFA and TFA diets for 12 weeks to induce obesity. Metabolic parameters such as body weight, blood glucose, blood lipids, liver enzymes, and body fat percentage were assessed. Anxiety-like behaviors were evaluated using the Open Field and Sucrose Preference Tests in Weeks 11 and 12. The effect of 7-NI (an nNOS inhibitor) on anxiety was also tested. Both diets induced obesity, glucose and lipid metabolism disorders, impaired liver function, and anxiety-like behaviors. SFA resulted in greater weight gain, while TFA caused more severe blood glucose dysregulation and hepatic dysfunction. No significant difference in nNOS protein expression was observed between the groups. However, 7-NI improved anxiety-like behaviors in SFA-fed but not TFA-fed mice. SFA primarily caused greater physical obesity, whereas TFA led to more pronounced metabolic damage. The nNOS inhibitor 7-NI reduced anxiety-like behaviors in SFA-induced obese mice but was ineffective in TFA-induced obesity, highlighting distinct metabolic and behavioral effects between these two types of fatty acids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.